Frances Oldham Kelsey papers, 1890-2016 (Library of Congress Finding Aid)

Access restrictions apply.Some or all content stored offsite.

Container	Contents

	Part II: Subject File, 1902-2012 (continued)
BOX II:100		Benoxaprofen (Oraflex), 1983-1988 See also Container II:139, Eli Lilly and Co. Task Group
BOX II:100		Beta-blockers See Container II:98, Antihypertensives
BOX II:100		Bioavailability, 1971, 1984-1991
BOX II:100		Biopharmaceutics, 1981, 1989
BOX II:100		Bioresearch Monitoring Program (BIMO), U.S. Food and Drug Administration
BOX II:100			Automatic Data Processing budget, 1983-1985
BOX II:100			Clinical Investigations Data File System, 1969, 1979-198-1983, 1999, undated
				(3 folders)
BOX II:101			Clinical investigators form and clinical facilities file system, 1969-1975, 1999, undated
BOX II:101			General
BOX II:101				1971-1979
					(7 folders)
BOX II:101				1980
					(1 folder)
BOX II:102					(1 folder)
BOX II:102				1981-1982
					(5 folders)
BOX II:102				1983
					(1 folder)
BOX II:103					(1 folder)
BOX II:103				1984-1999, undated
					(4 folders)
BOX II:103			Information Systems User Committee/BIMO Systems Task Group
BOX II:103				Chronology, 1979-1980
BOX II:103				General
BOX II:103					1977-1978
						(2 folders)
BOX II:103					1979
						(1 folder)
BOX II:104						(1 folder)
BOX II:104					1980-1982
						(6 folders)
BOX II:105					1983, 1999
						(4 folders)
BOX II:105				Presentation to BIMO Steering Committee, 1978, 1999
BOX II:105			Key events in National Center for Drugs and Biologics, circa 1981
BOX II:105			Meetings
BOX II:105				BIMO program managers
BOX II:105					1996
						(5 folders)
BOX II:106					1997
						(10 folders)
BOX II:106				Compliance Coordinating Committee, 1996
BOX II:106			Project Management Systems, implementation sessions
BOX II:106				1975-1980
					(3 folders)
BOX II:107				1981-1983
					(2 folders)
BOX II:107			Reports
BOX II:107				Annual, Fiscal Year 1980-Fiscal Year 1984
					(5 folders)
BOX II:107				Monthly
BOX II:107					1984
BOX II:108					1985-1988
						(6 folders)
BOX II:108					1989
BOX II:108						Jan.-Mar.
							(2 folders)
BOX II:109						Apr.-Nov.
							(6 folders)
BOX II:110						Dec.
BOX II:110					1990
						(4 folders)
BOX II:110					1991
BOX II:110						Jan.-July
							(2 folders)
BOX II:111						Aug.-Dec.
							(2 folders)
BOX II:111					1992
						(5 folders)
BOX II:112					1993
						(4 folders)
BOX II:112					1994
BOX II:112						Jan.-Apr.
							(2 folders)
BOX II:113						May-Dec.
							(3 folders)
BOX II:113					1995
BOX II:113						Jan.-Aug.
							(3 folders)
BOX II:114						Sept.-Dec.
BOX II:114					1996
						(5 folders)
BOX II:114			Transfer of classification No Action Indicated for BIMO inspection reports to field offices, 1979
BOX II:114			Work plans, 1987-1990
BOX II:115		Birth defects/reviews, 1976, 1986-1990
BOX II:115		Birth surveys, 1963-1999, undated
			(4 folders)
BOX II:115		Breast milk, drugs in, 1947-1993, 2001, undated
			(2 folders)
BOX II:116		Bromocryptine, 1977-1985
BOX II:116		Bureau of Drugs, U.S. Food and Drug Administration
BOX II:116			Clinical Investigator Stratified Surveillance Strategy, 1976-1980, undated
BOX II:116			Deputy director, 1979-1982
				(2 folders)
BOX II:116		Caffeine, 1966, 1978-1982, undated
BOX II:116		Carcinogenesis/teratology, 1963-1983, undated
BOX II:116		Carrisyn/Carrington Laboratories, Dallas, Tex., 1986-1996
			(2 folders)
BOX II:116		Celebrex/Vioxx, 1999-2002
BOX II:117		Center for Drug Evaluation and Research, U.S. Food and Drug Administration
BOX II:117			General, 1997-2000, undated
BOX II:117			Reports, 1992-1995
				(3 folders)
BOX II:117			Research Steering Committee
BOX II:117				1987-1988
					(3 folders)
BOX II:118				1990-1991
BOX II:118			Time reporting system, 1997-1999
BOX II:118		Chelation therapy, 2001
BOX II:118		Chick embryo studies, 1962-1972
BOX II:118		Chloramphenicol (Chloromycetin), 1962-1967, 1996-1997
BOX II:118		Chymopapain (Discase), 1973-1976, 1984, 1997-2000
BOX II:118		Chymotrypsin See Container II:140, Enzymes
BOX II:118		Clinical Investigator Conflict of Interest Task Force, U.S. Food and Drug Administration
BOX II:118			1987-1991
				(3 folders)
BOX II:118			1992
				(1 folder)
BOX II:119				(1 folder)
BOX II:119			1993-2000, undated
BOX II:119		Clinical trials, 1981, 1990, 1999, undated
BOX II:119		Clomiphene (Clomid), 1961-1989, undated
BOX II:119		Close, John H., 1977-1978, 1999
BOX II:119		Cobalt summary, Ray D. Uphoff and Albert L. Maduska, 1966, undated
Next Page »

Frances Oldham Kelsey papers, 1890-2016

Contents List